자산수익률비율 (ROA)
2005년부터
계산
Regeneron Pharmaceuticals Inc., ROA, 장기 추세계산
| ROA | = | 100 | × | 순이익(손실)1 | ÷ | 총 자산1 | |
|---|---|---|---|---|---|---|---|
| 2023. 12. 31. | 11.95% | = | 100 | × | 3,953,600) | ÷ | 33,080,200) |
| 2022. 12. 31. | 14.85% | = | 100 | × | 4,338,400) | ÷ | 29,214,500) |
| 2021. 12. 31. | 31.75% | = | 100 | × | 8,075,300) | ÷ | 25,434,800) |
| 2020. 12. 31. | 20.47% | = | 100 | × | 3,513,200) | ÷ | 17,163,300) |
| 2019. 12. 31. | 14.29% | = | 100 | × | 2,115,800) | ÷ | 14,805,200) |
| 2018. 12. 31. | 20.83% | = | 100 | × | 2,444,400) | ÷ | 11,734,500) |
| 2017. 12. 31. | 13.67% | = | 100 | × | 1,198,511) | ÷ | 8,764,286) |
| 2016. 12. 31. | 12.84% | = | 100 | × | 895,522) | ÷ | 6,973,466) |
| 2015. 12. 31. | 11.34% | = | 100 | × | 636,056) | ÷ | 5,609,132) |
| 2014. 12. 31. | 8.99% | = | 100 | × | 348,074) | ÷ | 3,871,827) |
| 2013. 12. 31. | 14.38% | = | 100 | × | 424,362) | ÷ | 2,951,013) |
| 2012. 12. 31. | 36.06% | = | 100 | × | 750,269) | ÷ | 2,080,490) |
| 2011. 12. 31. | -16.75% | = | 100 | × | (221,760) | ÷ | 1,323,583) |
| 2010. 12. 31. | -9.59% | = | 100 | × | (104,468) | ÷ | 1,089,432) |
| 2009. 12. 31. | -9.15% | = | 100 | × | (67,830) | ÷ | 741,202) |
| 2008. 12. 31. | -12.34% | = | 100 | × | (82,710) | ÷ | 670,038) |
| 2007. 12. 31. | -11.28% | = | 100 | × | (105,600) | ÷ | 936,258) |
| 2006. 12. 31. | -17.49% | = | 100 | × | (102,337) | ÷ | 585,090) |
| 2005. 12. 31. | -22.54% | = | 100 | × | (95,446) | ÷ | 423,501) |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
1 US$ 단위 천
경쟁사와의 비교
Regeneron Pharmaceuticals Inc., ROA, 장기 추세, 경쟁사와의 비교
| Regeneron Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023. 12. 31. | 11.95% | 3.61% | 6.91% | 8.43% | 5.64% | 8.19% | 9.12% | 20.98% | 0.34% | -25.58% | 0.94% | 6.07% |
| 2022. 12. 31. | 14.85% | 8.53% | 10.06% | 6.53% | 8.55% | 12.62% | 7.27% | 9.57% | 13.30% | 32.34% | 15.91% | 7.15% |
| 2021. 12. 31. | 31.75% | 7.88% | 9.63% | 6.40% | 7.73% | 11.44% | 9.16% | 11.47% | 12.35% | 49.46% | 12.11% | 8.12% |
| 2020. 12. 31. | 20.47% | 3.07% | 11.54% | -7.61% | 4.79% | 13.28% | 0.18% | 8.41% | 7.72% | -10.18% | 6.23% | 9.23% |
| 2019. 12. 31. | 14.29% | 8.84% | 13.13% | 2.65% | 4.85% | 21.17% | 8.74% | 9.59% | 11.66% | -32.34% | 9.72% | 6.33% |
| 2018. 12. 31. | 20.83% | 9.58% | 12.64% | 14.06% | 5.54% | 7.36% | 8.57% | 10.00% | 7.53% | -19.61% | 7.00% | 5.22% |
| 2017. 12. 31. | 13.67% | 7.50% | 2.48% | 3.00% | 5.34% | -0.45% | 6.58% | 0.83% | 2.72% | — | 12.40% | 3.93% |
| 2016. 12. 31. | 12.84% | 9.01% | 9.95% | 13.22% | 5.64% | 7.05% | 23.70% | 11.71% | 4.11% | — | 4.20% | 4.40% |
| 2015. 12. 31. | 11.34% | 9.70% | 9.69% | 4.93% | 6.96% | 6.77% | 34.93% | 11.55% | 4.36% | — | 4.16% | 4.83% |
| 2014. 12. 31. | 8.99% | 6.44% | 7.47% | 5.94% | 7.02% | 6.43% | 34.91% | 12.45% | 12.12% | — | 5.40% | 4.42% |
| 2013. 12. 31. | 14.38% | 14.14% | 7.68% | 6.64% | 7.77% | 13.29% | 13.67% | 10.42% | 4.17% | — | 12.78% | 4.00% |
| 2012. 12. 31. | 36.06% | 19.53% | 8.00% | 5.46% | 7.26% | 11.89% | 12.20% | 8.94% | 5.81% | — | 7.84% | 4.29% |
| 2011. 12. 31. | -16.75% | — | 7.54% | 11.25% | 7.25% | 12.92% | 16.20% | 8.51% | 5.97% | — | 5.32% | 4.96% |
| 2010. 12. 31. | -9.59% | — | 10.64% | 9.98% | 8.07% | 16.35% | 25.03% | 12.96% | 0.81% | — | 4.23% | 4.85% |
| 2009. 12. 31. | -9.15% | — | 11.62% | 34.22% | 5.88% | 15.76% | 27.18% | 12.95% | 11.51% | — | 4.05% | 3.93% |
| 2008. 12. 31. | -12.34% | — | 11.51% | 17.76% | 7.53% | -7.09% | 28.65% | 15.25% | 16.54% | — | 7.29% | 4.71% |
| 2007. 12. 31. | -11.28% | — | 9.14% | 8.27% | 7.84% | 11.02% | 27.68% | 13.06% | 6.77% | — | 7.07% | 3.59% |
| 2006. 12. 31. | -17.49% | — | 8.73% | 6.20% | 8.72% | 12.13% | -29.12% | 15.67% | 9.95% | — | 16.84% | 0.79% |
| 2005. 12. 31. | -22.54% | — | 12.54% | 10.66% | 9.80% | 8.05% | 21.62% | 17.94% | 10.33% | — | 6.88% | 5.25% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
산업 부문과의 비교: 제약, 생명공학 및 생명과학
Regeneron Pharmaceuticals Inc., ROA, 장기 추세, 산업 부문과 비교: 제약, 생명공학 및 생명과학
| Regeneron Pharmaceuticals Inc. | 제약, 생명공학 및 생명과학 | |
|---|---|---|
| 2023. 12. 31. | 11.95% | 6.57% |
| 2022. 12. 31. | 14.85% | 11.04% |
| 2021. 12. 31. | 31.75% | 11.19% |
| 2020. 12. 31. | 20.47% | 5.14% |
| 2019. 12. 31. | 14.29% | 8.90% |
| 2018. 12. 31. | 20.83% | 8.71% |
| 2017. 12. 31. | 13.67% | 5.27% |
| 2016. 12. 31. | 12.84% | 8.66% |
| 2015. 12. 31. | 11.34% | 9.03% |
| 2014. 12. 31. | 8.99% | 9.59% |
| 2013. 12. 31. | 14.38% | 9.55% |
| 2012. 12. 31. | 36.06% | 8.35% |
| 2011. 12. 31. | -16.75% | 7.32% |
| 2010. 12. 31. | -9.59% | 7.23% |
| 2009. 12. 31. | -9.15% | 10.17% |
| 2008. 12. 31. | -12.34% | 10.52% |
| 2007. 12. 31. | -11.28% | 8.98% |
| 2006. 12. 31. | -17.49% | 12.00% |
| 2005. 12. 31. | -22.54% | 10.50% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).
업계와의 비교: 의료
Regeneron Pharmaceuticals Inc., ROA, 장기 추세, 업계와의 비교: 의료
| Regeneron Pharmaceuticals Inc. | 의료 | |
|---|---|---|
| 2023. 12. 31. | 11.95% | 6.08% |
| 2022. 12. 31. | 14.85% | 8.60% |
| 2021. 12. 31. | 31.75% | 8.69% |
| 2020. 12. 31. | 20.47% | 5.36% |
| 2019. 12. 31. | 14.29% | 7.15% |
| 2018. 12. 31. | 20.83% | 6.08% |
| 2017. 12. 31. | 13.67% | 5.31% |
| 2016. 12. 31. | 12.84% | 6.93% |
| 2015. 12. 31. | 11.34% | 7.37% |
| 2014. 12. 31. | 8.99% | 8.18% |
| 2013. 12. 31. | 14.38% | 8.29% |
| 2012. 12. 31. | 36.06% | 7.68% |
| 2011. 12. 31. | -16.75% | 7.00% |
| 2010. 12. 31. | -9.59% | 6.99% |
| 2009. 12. 31. | -9.15% | 9.19% |
| 2008. 12. 31. | -12.34% | 8.56% |
| 2007. 12. 31. | -11.28% | 8.18% |
| 2006. 12. 31. | -17.49% | 9.77% |
| 2005. 12. 31. | -22.54% | 9.09% |
보고서 기준: 10-K (보고 날짜: 2023-12-31), 10-K (보고 날짜: 2022-12-31), 10-K (보고 날짜: 2021-12-31), 10-K (보고 날짜: 2020-12-31), 10-K (보고 날짜: 2019-12-31), 10-K (보고 날짜: 2018-12-31), 10-K (보고 날짜: 2017-12-31), 10-K (보고 날짜: 2016-12-31), 10-K (보고 날짜: 2015-12-31), 10-K (보고 날짜: 2014-12-31), 10-K (보고 날짜: 2013-12-31), 10-K (보고 날짜: 2012-12-31), 10-K (보고 날짜: 2011-12-31), 10-K (보고 날짜: 2010-12-31), 10-K (보고 날짜: 2009-12-31), 10-K (보고 날짜: 2008-12-31), 10-K (보고 날짜: 2007-12-31), 10-K (보고 날짜: 2006-12-31), 10-K (보고 날짜: 2005-12-31).